Dr. Andrew Ernest Fintel, DO

Dr. Fintel practices at Blue Ridge Cancer Care in Roanoke, Virginia.

Dr. Fintel's NPI, 1578876843, was assigned on July 15, 2010. Dr. Fintel holds Virginia license 0102204366.

Dr. Fintel's primary practice is Blue Ridge Cancer Care, at 2013 Jefferson SW St, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 982-0237.

Dr. Fintel's primary practice is Blue Ridge Cancer Care in Roanoke, Virginia. Dr. Fintel is also affiliated with Carilion Roanoke Memorial Hospital. The medical group on file is Blue Ridge Cancer Care. Dmand AI also links Dr. Fintel to 4 more hospitals, 2 home health agencies and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fintel practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fintel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fintel is licensed in Virginia.

CMS data shows 69,881 Medicare services from Dr. Fintel across 64 procedure codes in 2024, for 941 Medicare patients. Medicare paid $1,326,848 for them.

CMS counts 941 Medicare patients who saw Dr. Fintel in 2024. The largest group is 65 to 74, with 407 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fintel's median patient age at 71, with 62% women.

In 2024, Dr. Fintel wrote 2,144 Medicare Part D claims for 365 patients. 84% of them were for generic drugs. CMS names the drug for 1,759 of them, across 42 drugs with 11 or more claims each, at $2,173,051 in total drug cost. In 2023, CMS named 1,389 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fintel for performance year 2024, reported through an alternative payment model (APM). Dr. Fintel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fintel as offering telehealth.

Dmand AI links 3 papers to Dr. Fintel in 2014. The most frequent topics are SEER Program. Dr. Fintel's most frequent co-authors are Paxton V. Dickson, MD, Smith Giri and Omer Hassan Jamy.

CMS Open Payments shows 132 general payments to Dr. Fintel from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,370.